Oscar Health Inc (OSCR)
Official siteHEALTHCARE • HEALTHCARE PLANS • NYSE
Market Cap: $9.65B
Last updated: Nov 17, 2026 at 11:06 AM ET
Oscar Health Inc (OSCR) P/E Ratio & Valuation Multiples
Oscar Health (OSCR) trades at 12.9x trailing earnings and 0.6x sales. Its P/S of 0.6x is above its 5-year median of 0.4x. Its forward P/E is 588.2x. The median P/E across 12 similar companies is 22.9x.
Current Multiples
Its forward P/E is above its trailing P/E, which implies earnings per share about 97.8% lower over the next year. Its free cash flow yield is 42.7%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 12.9x |
| Forward P/E | 588.2x |
| Price to sales | 0.6x |
| Price to book | 4.4x |
| EV/EBITDA | 6.1x |
| Price to FCF | 2.3x |
| EV/FCF | 1.4x |
| PEG | N/A |
| FCF yield | 42.7% |
Historical Medians
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/S | 0.6x | 0.4x | N/A |
| P/B | 4.4x | 2.9x | N/A |
Valuation History
Over the 5 year ends shown, its P/S ranged from 0.1x in 2022 to 0.7x in 2021.
| Year end | Price | P/S | P/B |
|---|---|---|---|
| 2025 | $14.37 | 0.3x | 4.2x |
| 2024 | $13.44 | 0.4x | 3.5x |
| 2023 | $9.15 | 0.3x | 2.6x |
| 2022 | $2.46 | 0.1x | 0.6x |
| 2021 | $7.85 | 0.7x | 1.2x |
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About OSCR
What is OSCR's forward P/E ratio?
Oscar Health has a forward P/E ratio of 588.2x.
Is OSCR stock overvalued?
GNG's valuation label for OSCR is Fairly valued. Its P/E of 12.9x compares with a median of 22.9x across 12 similar companies.
What is OSCR's price to sales ratio?
Oscar Health has a price to sales ratio of 0.6x.
OSCR pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors